Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.505 USD | +2.24% | -1.93% | +49.41% |
Apr. 23 | Capital One Starts Heron Therapeutics With Overweight Rating, $6 Price Target | MT |
Mar. 21 | Heron Therapeutics, Inc. Announces Executive Changes, Effective March 29, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.41% | 368M | |
+2.37% | 42.75B | |
+48.04% | 41.61B | |
+11.94% | 41.34B | |
-12.36% | 26.59B | |
+8.52% | 25.49B | |
-24.25% | 18.12B | |
+30.20% | 12.24B | |
-1.84% | 11.76B | |
+7.64% | 11B |
- Stock Market
- Equities
- HRTX Stock
- News Heron Therapeutics, Inc.
- Transcript : Heron Therapeutics, Inc., Q4 2023 Earnings Call, Mar 12, 2024